GPP, PPP and SJS: Typical Patient Journey

Video

Experts discuss the typical journey of a patient with rare dermatologic conditions.

Recent Videos
Discussing the Global Prevalence of Seborrheic Dermatitis, with Raj Chovatiya, MD, PhD
Crisis Point: Improving Diversity in Dermatology
Brett King, MD, PhD | Credit: Yale University
Discussing Post-Hoc Data on Ruxolitinib for Nonsegmental Vitiligo, with David Rosmarin, MD
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
© 2024 MJH Life Sciences

All rights reserved.